drugset / Trial / NCT06917859

Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass

NCT06917859

Phase 1 Recruiting 170 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of the planned study is to assess the prophylactic effect of intraoperative administration of a single dose of methylprednisolone 2 (mg/kg) in decreasing the incidence of postoperative acute kidney injury after cardiac surgeries with cardiopulmonary bypass.

Timeline

Start
2025-02-01
Primary completion
2026-02-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 2 mg/kg Intravenous

Indications